Delivery Order SPE2DB20D3303-SPE2DB25FA1EK
Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $17,491.89 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of 36,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Creon is a pharmaceutical enzyme replacement therapy used to treat pancreatic insufficiency and digestive disorders,...
- The Defense Logistics Agency awarded a delivery order valued at $5,198.70 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, reflecting DLA's role in supplying...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of 24,000 units of Creon DR 100s capsules, with a contract ceiling value of $7,467.22. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,088.91 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 mg capsules. This non-competitive, firm fixed price delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $25,167.42 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules under a firm fixed-price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, valued at $6,347.59, with an ultimate completion date of August 26, 2025. This firm fixed price, non-set-aside contract was awarded on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine procurement of pharmaceutical products supporting federal medical supply chain...
- The Defense Logistics Agency awarded a $7,093.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for 36,000 units of Creon DR 100-strength capsules, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a single delivery order for pharmaceutical supplies to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,816.32 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s. This order was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. The contract employs firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Creon DR is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency,...
- The Defense Logistics Agency awarded a delivery order valued at $1,616.16 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement therapy commonly prescribed for patients with pancreatic insufficiency. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be executed from...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication used to treat pancreatic insufficiency. This non-competitive, firm fixed-price delivery order, valued at $4,919.22, was awarded on May 2, 2025, with an ultimate completion date of May 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...